Authors
Loading...
Investigation shows integrin β3 disrupts ROCK signaling in megakaryocytes, indicating potential targets for thrombocytopenia treatment.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: